Inventor · disambiguated record
Marc Vandermeeren
Also filed as: VANDERMEEREN MARC · VANDERMEEREN MARC MARIA PIERRE · VANDERMEEREN MARC MARIA PIERRE PELAGIE
19 granted patents·5 pending applications·332 citations·filing 1993–2020
95Inventor score
Files withINNOGENETICS NV12JANSSEN BIOTECH INC4JANSSEN PHARMACEUTICA NV4MERCKEN MARC HUBERT2INNOGENETICS SA1
Top patents by PatentIndex Score
24 records- 0193US6238892B1Monoclonal antibodies directed against the microtubule-associated protein tauINNOGENETICS NV·Filed 1996·Granted May 29, 2001·84 cites·3 claims
- 0291US10851156B2Methods of detecting pyroglutamate amyloid beta protein (3pE Aβ) using anti-3pE Aβ antibodiesJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Dec 1, 2020·8 cites·15 claims
- 0391US9371376B2Anti-PHF-tau antibodies and their usesJANSSEN BIOTECH INC·Filed 2012·Granted Jun 21, 2016·10 cites·11 claims
- 0490US10519223B2Antibodies to pyroglutamate amyloid-β and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Dec 31, 2019·5 cites·16 claims
- 0589US6900293B2Monoclonal antibodies directed against the microtubule-associated protein tauINNOGENETICS NV·Filed 2000·Granted May 31, 2005·14 cites·8 claims
- 0688US10196440B2Anti-PHG-tau antibodies and their usesJANSSEN BIOTECH INC·Filed 2018·Granted Feb 5, 2019·3 cites·8 claims
- 0784US10000559B2Anti-PHF-tau antibodies and their usesJANSSEN BIOTECH INC·Filed 2017·Granted Jun 19, 2018·2 cites·18 claims
- 0883US8163873B2Isolated microtubule-associated protein tau peptides and kitMERCKEN MARC·Filed 2008·Granted Apr 24, 2012·11 cites·5 claims
- 0982US5843779AMonoclonal antibodies directed against the microtubule-associated protein tau, and hybridomas secreting these antibodiesINNOGENETICS NV·Filed 1993·Granted Dec 1, 1998·51 cites·2 claims
- 1078US6008024AMonoclonal antibodies specific for PHF-tau, hybridomas secreting them, antigen recognition by these antibodies and their applicationsINNOGENETICS NV·Filed 1994·Granted Dec 28, 1999·32 cites·8 claims
- 1177US9939452B2N-11 truncated amyloid-beta monoclonal antibodies, compositions, methods and usesJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Apr 10, 2018·2 cites·2 claims
- 1277US6500674B1Method for the diagnosis of brain/neurological disease using monoclonal antibodies specific for PHF-tau, hybridomas secreting them, and antigen recognition by these antibodies and their applicationsINNOGENETICS NV·Filed 1999·Granted Dec 31, 2002·20 cites·32 claims
- 1377US6010913AIsolated human tau peptideINNOGENETICS NV·Filed 1995·Granted Jan 4, 2000·36 cites·2 claims
- 1477US5861257AMonoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applicationsINNOGENETICS NV·Filed 1995·Granted Jan 19, 1999·21 cites·4 claims
- 1575US9745371B2Anti-PHF-tau antibodies and their usesJANSSEN BIOTECH INC·Filed 2016·Granted Aug 29, 2017·1 cites·15 claims
- 1670US9329189B2N-11 truncated amyloid-beta Aβ11-x monoclonal antibodies and compositionsMERCKEN MARC HUBERT·Filed 2003·Granted May 3, 2016·6 cites·4 claims
- 1770US6232437B1Isolated human tau peptide epitope which specifically binds monoclonal antibody AT120.INNOGENETICS NV·Filed 1999·Granted May 15, 2001·25 cites·2 claims
- 1868US11673943B2Methods of binding amyloid beta protein having pyroglutamate at the third amino acid residue (3pE abeta) in vivo using anti-3pE abeta antibodies or antigen-binding fragments thereofJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Jun 13, 2023·0 cites·21 claims
- 1967US8911731B2Monoclonal antibodies specific for beta-amyloid x-37 and uses thereofMERCKEN MARC HUBERT·Filed 2012·Granted Dec 16, 2014·1 cites·7 claims
- 2063US2004038430A1Monoclonal antibodies specific for PHF-TAU, hybridomas secreting them, antigen recognition by these antibodies and their applicationsINNOGENETICS NV·Filed 2003·Application pending·0 cites
- 2162US2003143760A1Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applicationsINNOGENETICS SA·Filed 2002·Application pending·0 cites
- 2261US2003138972A1Monoclonal antibodies specific PHF-TAU, hybridomas secreting them, antigen recognition by these antibodies and their applicationsINNOGENETICS NV·Filed 2002·Application pending·0 cites
- 2357US2002001857A1Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applicationsINNOGENETICS NV·Filed 2001·Application pending·0 cites
- 2453US2006008853A1Monoclonal antibodies directed against the microtubule-associated protein tau and method of detecting the sameINNOGENETICS NV·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marc Vandermeeren files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →